We also observed faster tumor growth in the miR-124 inhibitor group compared with the control group and the miR-124 inhibitor+MALAT1-siRNA inversed the effect of the miR-124 inhibitor on tumor growth in vivo (Figure 5A and 5B). Here, MALAT1 is linked to neoplasm.